Publications en collaboration avec des chercheurs de Gustave Roussy Cancer Campus (13)

2021

  1. Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)

    Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390

2020

  1. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report from the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

    Journal of Clinical Oncology, Vol. 38, Núm. 31, pp. 3685-3697

2018

  1. Genomic amplifications and distal 6q loss: Novel markers for poor survival in high-risk neuroblastoma patients

    Journal of the National Cancer Institute, Vol. 110, Núm. 10

2015

  1. Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

    Clinical Cancer Research, Vol. 21, Núm. 8, pp. 1904-1915

2013

  1. Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study

    European Journal of Cancer, Vol. 49, Núm. 17, pp. 3671-3679

2011

  1. A multilocus technique for risk evaluation of patients with neuroblastoma

    Clinical Cancer Research, Vol. 17, Núm. 4, pp. 792-804

  2. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

    British Journal of Cancer, Vol. 105, Núm. 12, pp. 1940-1948

2009

  1. Histological heterogeneity of Ewing's sarcoma/PNET: An immunohistochemical analysis of 415 genetically confirmed cases with clinical support

    Virchows Archiv, Vol. 455, Núm. 5, pp. 397-411

  2. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

    The Lancet Oncology, Vol. 10, Núm. 7, pp. 663-671

1989

  1. Fibroblast and Myofibroblast Participation in Malignant Fibrous Histiocytoma (MFH) of Bone: Ultrastructural Study of Eight Cases with Immunohistochemical Support

    Pathology Research and Practice, Vol. 184, Núm. 6, pp. 582-590

1987

  1. Giant cell tumors of maxilla

    Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Société d'oto-laryngologie des hôpitaux de Paris, Vol. 104, Núm. 4, pp. 251-257

  2. S-100 protein positive cells in nasopharyngeal carcinoma (NPC): Absence of prognostic significance - A clinicopathological and immunohistochemical study of 40 cases

    Virchows Archiv A Pathological Anatomy and Histopathology, Vol. 411, Núm. 3, pp. 233-237

1984

  1. FIBROHISTIOCYTOMES MALINS DES TISSUS MOUS. ANATOMIE PATHOLOGIQUE

    Archives d'Anatomie et de Cytologie Pathologiques, Vol. 32, Núm. 4, pp. 202-207